* U.S. shares of Deutsche Bank up 2.2 pct
* Darden up as 1st-qtr sales rise
* Indexes up: Dow 0.21 pct, S&P 0.13 pct, Nasdaq 0.34 pct
(Updates to open)
By Yashaswini Swamynathan
Oct 4 Wall Street edged higher on Tuesday
morning, helped by a rise in technology stocks and a rebound in
The S&P 500 technology index rose 0.43 percent,
boosted by a 1.2 percent rise in Apple and a 0.6
percent rise in Google parent Alphabet.
The benchmark S&P 500 index has been swinging between gains
and losses in the past few days as investors await the upcoming
corporate earnings season and the outcome of a tight race for
the White House.
Deutsche Bank shares rose 2.2 percent after major
clients and rivals extended support to the bank, which is
negotiating with U.S. authorities over a multi-billion dollar
The German lender's U.S.-listed stock was also up 2.2
At 9:44 a.m. ET (1344 GMT) Dow Jones industrial average
was up 38.89 points, or 0.21 percent, at 18,292.74.
The S&P 500 was up 2.77 points, or 0.13 percent, at
2,163.97. Five of the 11 major S&P 500 indexes were higher.
The Nasdaq Composite was up 17.90 points, or 0.34
percent, at 5,318.77.
Richmond Federal Reserve President Jeffrey Lacker said he
would have dissented at the last rate-setting meeting if he had
been able to vote, arguing that interest rates need to rise.
His Cleveland counterpart, Loretta Mester, who unlike Lacker
is a voting member of the Fed, said on Monday that the central
bank should not delay raising rates.
The September jobs report on Friday will give a glimpse into
the health of the U.S. labor market and play a big role in the
Fed's decision on interest rates.
Traders have priced in a mere 10 percent chance of a hike at
the Fed's November meeting, which comes days before the Nov. 8
U.S. presidential election. The odds of a December hike stand at
62 percent, according to the CME Group's FedWatch tool.
Darden shares rose 4.6 percent to $64.15 in
premarket trading after the restaurant chain operator reported a
rise in first-quarter sales.
Netflix rose 1.1 percent to $103.81 amid
speculation that the company could be a takeover target.
Sarepta Therapeutics rose 0.7 percent after
entering an agreement with Summit Therapeutics to
develop drugs to treat Duchenne muscular dystrophy. Summit's
U.S.-listed stock more than doubled.
Pandora rose 4.6 percent after Goldman Sachs added the
stock to its "conviction list" and raised its price target.
Advancing issues outnumbered decliners on the NYSE by 1,467
to 1,176. On the Nasdaq, 1,438 issues rose and 847 fell.
The S&P 500 index showed 11 new 52-week highs and two new
lows, while the Nasdaq recorded 37 new highs and nine new lows.
(Reporting by Yashaswini Swamynathan in Bengaluru; Editing by